Tickets for Kartemquin’s Spring Showcase are now on sale. It will take place on May 19th at the Gene Siskel Film Center and will feature exclusive previews of four upcoming films. Find more information here: http://kartemquin.com/node/5756
Pop-upView Separately

Tickets for Kartemquin’s Spring Showcase are now on sale. It will take place on May 19th at the Gene Siskel Film Center and will feature exclusive previews of four upcoming films. Find more information here: http://kartemquin.com/node/5756

Forty-six years ago on April 28th, Muhammad Ali refused to be inducted into the army.The Trials of Muhammad Ali by Bill Siegel explores the consequences this refusal had on the boxer’s career. http://www.huffingtonpost.com/2013/04/28/today-in-history-muhammad-ali-army_n_3172239.html
Pop-upView Separately

Forty-six years ago on April 28th, Muhammad Ali refused to be inducted into the army.

The Trials of Muhammad Ali by Bill Siegel explores the consequences this refusal had on the boxer’s career. 

http://www.huffingtonpost.com/2013/04/28/today-in-history-muhammad-ali-army_n_3172239.html

Democracy Now! Has published exclusive clips from The Trials of Muhammad Ali, directed by Bill Siegel and produced by Gordon Quinn, here.  http://www.democracynow.org/2013/4/26/the_trials_of_muhammad_ali_boxing Siegel and Quinn also share their challenges while making the film.  The Trials of Muhammad Ali will premiere at the Tribeca Film Festival today. 
Pop-upView Separately

Democracy Now! Has published exclusive clips from The Trials of Muhammad Ali, directed by Bill Siegel and produced by Gordon Quinn, here. 

http://www.democracynow.org/2013/4/26/the_trials_of_muhammad_ali_boxing

Siegel and Quinn also share their challenges while making the film. 

The Trials of Muhammad Ali will premiere at the Tribeca Film Festival today. 

What to know more about the gene patent debate? The Economist explores the arguments against gene patenting. http://www.economist.com/blogs/economist-explains/2013/04/economist-explains-why-gene-patents-controversial The Supreme Court began hearing arguments about the legality of gene patenting on April 15th. To coincide with this, Joanna Rudnick’s documentary, In the Family, has been re-released here. 
Pop-upView Separately

What to know more about the gene patent debate? The Economist explores the arguments against gene patenting.

http://www.economist.com/blogs/economist-explains/2013/04/economist-explains-why-gene-patents-controversial

The Supreme Court began hearing arguments about the legality of gene patenting on April 15th. To coincide with this, Joanna Rudnick’s documentary, In the Family, has been re-released here. 

Slate summarizes the Supreme Court hearings of Association for Molecular Pathology, et al v. Myriad Genetics case while also providing anecdotes from women who have tried to get the BRCA test.  http://www.slate.com/articles/news_and_politics/supreme_court_dispatches/2013/04/human_gene_patents_at_the_supreme_court_slate_readers_tell_their_stories.html “One concern about Myriad’s monopoly is cost. Helen, who was diagnosed with breast cancer last February in California, says her genetic counselor suggested she should be tested, “to help with my decision making and to inform my sister, who if I tested positive would need to be watched carefully.” She says, “I spoke to my insurance company (Blue Cross/ Anthem) and they stated that the test would not be covered and the cost would be between $3,000 and $4,000.”  The issue of gene patenting is at the heart of Joanna Rudnick’s documentary, In the Family.  In the Family can be found online for free at  http://www.pbs.org/pov/inthefamily, now through May 15th. 
Pop-upView Separately

Slate summarizes the Supreme Court hearings of Association for Molecular Pathology, et al v. Myriad Genetics case while also providing anecdotes from women who have tried to get the BRCA test. 

http://www.slate.com/articles/news_and_politics/supreme_court_dispatches/2013/04/human_gene_patents_at_the_supreme_court_slate_readers_tell_their_stories.html

“One concern about Myriad’s monopoly is cost. Helen, who was diagnosed with breast cancer last February in California, says her genetic counselor suggested she should be tested, “to help with my decision making and to inform my sister, who if I tested positive would need to be watched carefully.” She says, “I spoke to my insurance company (Blue Cross/ Anthem) and they stated that the test would not be covered and the cost would be between $3,000 and $4,000.” 

The issue of gene patenting is at the heart of Joanna Rudnick’s documentary, In the Family. 

In the Family can be found online for free at  http://www.pbs.org/pov/inthefamily, now through May 15th.